Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Current Deferred Tax Assets (2019 - 2021)

Historic Current Deferred Tax Assets for Iterum Therapeutics (ITRM) over the last 3 years, with Q3 2021 value amounting to $45000.0.

  • Iterum Therapeutics' Current Deferred Tax Assets changed N/A to $45000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $45000.0, marking a year-over-year change of. This contributed to the annual value of $2.3 million for FY2019, which is N/A changed from last year.
  • Per Iterum Therapeutics' latest filing, its Current Deferred Tax Assets stood at $45000.0 for Q3 2021.
  • Iterum Therapeutics' 5-year Current Deferred Tax Assets high stood at $2.3 million for Q4 2019, and its period low was $37000.0 during Q2 2021.
  • For the 3-year period, Iterum Therapeutics' Current Deferred Tax Assets averaged around $797200.0, with its median value being $312000.0 (2020).
  • The largest annual percentage gain for Iterum Therapeutics' Current Deferred Tax Assets in the last 5 years was 9704.71% (2021), contrasted with its biggest fall of 9704.71% (2021).
  • Over the past 3 years, Iterum Therapeutics' Current Deferred Tax Assets (Quarter) stood at $2.3 million in 2019, then tumbled by 46.43% to $1.3 million in 2020, then plummeted by 96.41% to $45000.0 in 2021.
  • Its Current Deferred Tax Assets stands at $45000.0 for Q3 2021, versus $37000.0 for Q2 2021 and $1.3 million for Q2 2020.